Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
On August 12, 2021, Johnson & Johnson (NYSE: JNJ) announced its participation in the Morgan Stanley 19th Annual Global Healthcare Conference scheduled for September 15, 2021. The company will be represented by Joseph J. Wolk, Executive Vice President and CFO, and Mathai Mammen, Global Head of Research & Development, during a session at 9:30 a.m. (Eastern Time). Investors can access the live webcast via the Johnson & Johnson website, with a replay available 48 hours post-event.
- None.
- None.
NEW BRUNSWICK, N.J., Aug. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48-hrs after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-301354365.html
SOURCE Johnson & Johnson
FAQ
When will Johnson & Johnson participate in the Morgan Stanley Global Healthcare Conference?
Who will represent Johnson & Johnson at the Morgan Stanley conference?
What time is the Johnson & Johnson session scheduled at the conference?
Where can I watch the Johnson & Johnson conference webcast?
Will there be a replay of the Johnson & Johnson conference session?
